Rule 127. Authorization of off-Label Use of Drug Treatments for Pediatric Acute-Onset and Autoimmune Neuropsychiatric Syndrome
- 003.22.127–1. Authority
- 003.22.127–2. Definitions
- 003.22.127–3. Coverage Requirement Review
- 003.22.127–4. FDA Approval and Reporting
- 003.22.127–4. Coding Fee for Evaluation
- 003.22.127–5. Enforcement and Penalties
- 003.22.127–6. Effective Date
- Appendix A. University of Arkansas for Medical Sciences/Arkansas Children's Hospital Childhood Postinfectious Autoimmune Encephalopathy (Cpae) Center of Excellence